Skip to Main Content

Paper Details

Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies.
Cancers (Basel)
1
2023
-specific cytotoxic T lymphocytes, 4T1, 4T1-specific cytotoxic T lymphocytes, CD4, CD8, CTLA-4, CTLs, CXCR1/2, FSL-1, HMGN1, ICB, MDSC, Mice, Mouse, R848, SX682, TLR2/6, TLR7/8, TNBC, Triple-Negative Breast Carcinoma, Triple-negative breast carcinoma, anti-CTLA4 antibody, fibroblast-stimulating lipopeptide, high-mobility group nucleosome binding protein 1, infiltrating CD4+ and CD8+ effector/memory T cells, mice, murine, patients, resiquimod, solid-organ cancers, tumor, tumors
Author NameAffiliation
Udo RudloffCenter for Cancer Research, National Cancer Institute
Udo RudloffCenter for Cancer Research, National Cancer Institute
  • 1 - 2

Datasets

Release 1.2